Medical Marijuana, Inc. Subsidiary Kannaway® Announces New CBD Oil for Pets

SAN DIEGO, July 11, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary Kannaway® has released a cannabidiol (CBD) hemp oil for pets with no detectable levels of THC called Dante’s Pure Hemp Oil.

Dante’s Pure Hemp Oil is a CBD hemp oil with no detectable levels of THC that contains 1000 mg of CBD combined with MCT oil. This product offers an abundant number of terpenes, essential fatty acids and other cannabinoids found naturally in hemp. Its blend is all-natural and is Triple Lab Tested® for integrity, safety and consistency.

“We are excited to announce this new product at a time where there is an increase in studies being conducted on the therapeutic benefits of CBD for a variety of animals,” said Kannaway® CEO Blake Schroeder. “We are proud that our products, no matter if they are for people or pets, are the highest quality and that our company continues to be a leader in the cannabis industry.”

Dante’s Pure Hemp Oil can be given to your pet orally daily to help promote overall wellness and has been researched by top veterinarians for cardiovascular, orthopedic and mental animal health. It can be distributed on a treat or mixed in with food or water for easy consumption.

Dante’s Pure Hemp Oil is available for purchase now through the Kannaway® online store.

About Kannaway, LLC 

Kannaway, LLC, is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit

To see Medical Marijuana, Inc.’s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.


These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.


Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.


Public Relations Contact:

Andrew Hard

Chief Executive Officer CMW Media

P. 858-264-6600

[email protected]